-
PYROGENT® Bulk Gel Clot LAL Assay (without endotoxin)Catalog #: E194L-06Gel clot LAL assay for 1,250 tests. Kit does not contain endotoxin. Sensitivity: 0.06 EU/ml.Sales unit: kit
-
PYROGENT® Plus Bulk Gel Clot LAL Assay (with endotoxin)Catalog #: N494-03Gel clot LAL assay for 4,000 tests. Kit contains endotoxin. Sensitivity: 0.03 EU/ml.Sales unit: each
-
PYROGENT® Plus Bulk Gel Clot LAL Assay (with endotoxin)Catalog #: N288-25Gel clot LAL assay for 4,000 tests. Kit contains endotoxin. Sensitivity: 0.25 EU/ml.Sales unit: each
-
PYROGENT® Bulk Gel Clot LAL Assay (without endotoxin)Catalog #: F245U-125Gel clot LAL assay for 1,600 tests. Kit does not contain endotoxin. Sensitivity: 0.125 EU/ml.Sales unit: each
-
Control Standard Endotoxin for PYROGENT® Gel Clot LAL AssaysCatalog #: N186
Control Standard Endotoxin for PYROGENT® Gel Clot LAL Assays, E coli Strain O55:B5, 5 vials
Sales unit: each -
Human Peripheral Blood CD3+ Pan T Cells, Cryopreserved, 25 MillionCatalog #: 2W-350
Human CD3+ T cells, isolated from peripheral blood using negative immunomagnetic selection, ≥ 25 million cells, cryopreserved
Sales unit: Ampule -
MEGM® Mammary Epithelial Cell Growth Medium BulletKit®Catalog #: CC-3150
Culture system containing MEBM® Basal Medium (CC-3151) and MEGM® SingleQuots® Supplements (CC-4136) required for growth of Mammary Epithelial Cells.
Sales unit: kit -
TheraPEAK® MSCGMTM Mesenchymal Stem Cell Growth Medium BulletKit®Catalog #: BEBP18-936
TheraPEAK® MSCGMTM Mesenchymal Stem Cell Growth Medium BulletKit® including the basal medium and supplements, which is GMP-produced and serum-free, 1 L.
Sales unit: kit -
TheraPEAK® X-VIVO® 15 Serum-free Hematopoietic Cell MediumCatalog #: BEBP02-061Q
TheraPEAK® X-VIVO® 15 Serum-free Hematopoietic Cell Medium, with L-Glutamine, without gentamicin and phenol red, xenofree, 1 L
Sales unit: each -
TheraPEAK® X-VIVO® 15 Serum-free Hematopoietic Cell Medium with recombinant transferrinCatalog #: BEBP02-054Q
TheraPEAK® X-VIVO® 15, Serum-free Hematopoietic Cell Medium, with L-Glutamine, without gentamicin and phenol red, xenofree, 1 L
Sales unit: each
-
4D-Nucleofector® Protocol for PANC-1Optimized 384-well Nucleofector® and 4D-Nucleofector® Protocol for PANC-1
-
PANC-1 Transfection Protocol - 4D-Nucleofector™ X-UnitInstructions of use for transfection of PANC-1 cells with the SE Cell Line 4D-Nucleofector™ X Kit
-
PANC-1 Transfection Protocol - Nucleofector™ I/II/2b Device SeriesInstructions of use for transfection of PANC-1 cells with the Cell Line Nucleofector™ Kit R
-
Lonza Bioscience Clinical Technologies – Your Trusted Partner in Regenerative Medicine
-
The Importance of Cell-subtype Selection in Creation of a 3D Liver Fibrosis ModelData sheet detailing 3D liver fibrosis model in collaboration with Visikol
-
Instructions - QCL-1000™ Assay (English)Detailed instructions for performing the QCL-1000™ Endpoint Chromogenic LAL Assay
-
Metabolism_Brochure_CoBrand_FormThis is a co-marketing form for distributors. There is a restricted space on the cover next to the Lonza logo and on the back below the market bar. Art for placement MUST be a PDF. In addition there is space on the back cover for a web address at the top and contact and disclaimers. Please look for the instruction PDF in the literature DB Article number CD-FO006Inst
-
2018 Endotoxin Testing Summit Report: Entering a New Era for Endotoxin TestingWhite Paper Report provides an update on current trends from the key stakeholders in the endotixin testing community, gives details on the key topics discussed, and looks at what the future holds for endotoxin testing.
-
Lonza - Closer Than You Think - Corporate Brochure
-
Cell Therapy Services - Your Product. Our Passion.